Plain-English translation of NCT01788592 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study is following thousands of patients who receive drug-eluting stents — special metal tubes coated with medication that are placed in clogged heart arteries to keep them open. Researchers want to understand how well this treatment works and how safe it is when used in everyday hospital and clinic settings, rather than in highly controlled research environments. Your experience and health outcomes will help doctors learn whether this treatment continues to work well for patients like you.
Drug-coated stents have been tested in controlled research settings, but doctors need to know how they perform in real patients with different backgrounds and conditions. This study will help answer important questions about whether this treatment remains safe and effective when used across many different hospitals and patient groups.
You likely qualify if…
You likely don't qualify if…
You will receive a drug-coated stent as part of your standard heart care. The research team will then track your health and recovery over time, collecting information about how well the stent works and any side effects you experience. This is an observational study, meaning researchers will follow your outcomes rather than asking you to take additional medications or undergo extra procedures beyond your regular medical care.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
South Korea
Sponsor
Seung-Jung Park
Enrollment target
~50,000 participants
Started
January 2003
Primary completion
October 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.